A PLACEBO-CONTROLLED, MULTICENTER, DOUBLE-BLIND, RANDOMISED TRIAL OF EMRICASAN IN SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RAISED TRANSAMINASES

被引：19
|
作者：
Shiffman, M. [1 ]
Freilich, B. [2 ]
Vuppalanchi, R. [3 ]
Watt, K. [4 ]
Burgess, G. [5 ]
Morris, M. [5 ]
Sheedy, B. [5 ]
Schiff, E. [6 ]
机构：
[1] Bon Secours Hlth Syst Richmond & Newport News, Liver Inst Virginia, Richmond Newport News, VA USA
[2] Kansas City Res Inst, Kansas City, KS USA
[3] Indiana Univ Sch Med, Div Gastroenterol & Hepatol 3, Indianapolis, IN 46202 USA
[4] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
[5] Conatus Pharmaceut Inc, San Diego, CA USA
[6] Univ Miami, Div Hepatol, Miami, FL USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30191-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP37
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [41] Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
    Heeboll, Sara
    Kreuzfeldt, Martin
    Hamilton-Dutoit, Stephen
    Poulsen, Marianne Kjaer
    Stodkilde-Jorgensen, Hans
    Moller, Holger Jon
    Jessen, Niels
    Thorsen, Kasper
    Hellberg, Ylva Kristina
    Pedersen, Steen Bonlokke
    Gronbaek, Henning
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 456 - 463
  • [42] Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
    Cicero, Arrigo F. G.
    Sahebkar, Amirhossein
    Fogacci, Federica
    Bove, Marilisa
    Giovannini, Marina
    Borghi, Claudio
    EUROPEAN JOURNAL OF NUTRITION, 2020, 59 (02) : 477 - 483
  • [43] Effects of sumac (Rhus coriaria) on lipid profile, leptin and steatosis in patients with non-alcoholic fatty liver disease: A randomized double-blind placebo-controlled trial
    Ehsani, Simin
    Zolfaghari, Hamid
    Kazemi, Samira
    Shidfar, Farzad
    JOURNAL OF HERBAL MEDICINE, 2022, 31
  • [44] A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
    Saeed Chashmniam
    Seyed Reza Mirhafez
    Maryam Dehabeh
    Mitra Hariri
    Mohsen Azimi Nezhad
    B. Fatemeh Nobakht M. Gh
    European Journal of Clinical Nutrition, 2019, 73 : 1224 - 1235
  • [45] Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Mirhafez, Seyed Reza
    Farimani, Azam Rezaei
    Dehhabe, Maryam
    Bidkhori, Mohammad
    Hariri, Mitra
    Ghouchani, Bibi Fatemeh Nobakht Motlagh
    Abdollahi, Fatemeh
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (02) : 183 - 189
  • [46] Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
    Arrigo F. G. Cicero
    Amirhossein Sahebkar
    Federica Fogacci
    Marilisa Bove
    Marina Giovannini
    Claudio Borghi
    European Journal of Nutrition, 2020, 59 : 477 - 483
  • [47] A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
    Chashmniam, Saeed
    Mirhafez, Seyed Reza
    Dehabeh, Maryam
    Hariri, Mitra
    Nezhad, Mohsen Azimi
    Nobakht, B. Fatemeh M. Gh
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2019, 73 (09) : 1224 - 1235
  • [48] No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
    Ilaria Barchetta
    Maria Del Ben
    Francesco Angelico
    Michele Di Martino
    Antonio Fraioli
    Giuseppe La Torre
    Rosella Saulle
    Ludovica Perri
    Sergio Morini
    Claudio Tiberti
    Laura Bertoccini
    Flavia Agata Cimini
    Francesca Panimolle
    Carlo Catalano
    Marco Giorgio Baroni
    Maria Gisella Cavallo
    BMC Medicine, 14
  • [49] No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
    Barchetta, Ilaria
    Del Ben, Maria
    Angelico, Francesco
    Di Martino, Michele
    Fraioli, Antonio
    La Torre, Giuseppe
    Saulle, Rosella
    Perri, Ludovica
    Morini, Sergio
    Tiberti, Claudio
    Bertoccini, Laura
    Cimini, Flavia Agata
    Panimolle, Francesca
    Catalano, Carlo
    Baroni, Marco Giorgio
    Cavallo, Maria Gisella
    BMC MEDICINE, 2016, 14
  • [50] Randomized placebo-controlled trial of orlistat for the treatment of patients with non alcoholic fatty liver disease (NAFLD)
    Zelber-Sagi, S
    Kessler, A
    Brazowsky, E
    Webb, M
    Lurie, Y
    Santo, M
    Leshno, M
    Blendis, LM
    Halpern, Z
    Oren, R
    HEPATOLOGY, 2004, 40 (04) : 237A - 237A
12345